Cercar
26/08/2025
Outcomes with esketamine nasal spray in patients with or without earlier partial or full response: post hoc analyses of ESCAPE TRD
Young, AH, Godinov, Y, Rive, B, Ito, T, Buyze, J, Oliveira-Maia, AJ, Fagiolini, A, Cardoner, N, Gorwood, P, Mcintyre, RS, Demyttenaere, K. Outcomes with esketamine nasal spray in patients with or without earlier partial or full response: post hoc analyses of ESCAPE TRD. EUROPEAN PSYCHIATRY. 2025; 68DOI:10.1192/j.eurpsy.2025.861. PMID:. IF:6.700(Q1/1D).
25/08/2025
Understanding the structure of insight in eating disorders: validation of the SAI-ED in a Spanish clinical sample
Gawron, LP, Garrido-Ribas, I, Carmona-Farrés, C, Carril-Batuecas, S, Carceller-Sindreu, M, Avila-Parcet, A, Amaro-Carriba, MA, Hernández-Molina, M, Portella, MJ, Pousa, E. Understanding the structure of insight in eating disorders: validation of the SAI-ED in a Spanish clinical sample. Journal of Eating Disorders. 2025; 13(1)DOI:10.1186/s40337-025-01360-5. PMID:40855569. IF:4.500(Q1/1D).
22/08/2025
Reward-related neural activation during social media exposure in young women with non-suicidal self-injury: evidence for a continuum of severity in the reward network
Nicolaou, S, Julià, A, Otero, D, Schmidt, C, Pascual, JC, Soler, J, Marco-Pallarés, J, Vega, D. Reward-related neural activation during social media exposure in young women with non-suicidal self-injury: evidence for a continuum of severity in the reward network. Translational Psychiatry. 2025; 15(1)DOI:10.1038/s41398-025-03536-8. PMID:40846692. IF:6.200(Q1/1D).
11/08/2025
Validation and normative data for the BAC app in Spanish-speaking individuals with psychosis and healthy controls
González-Blanch, C, Pousa, E, Reguera-Pozuelo, P, Gutiérrez-Zotes, A, Rodriguez-Jimenez, R, del-Castillo-Serrano, M, González-Pinto, A, Cano-Escalera, G, Zubia, M, Sánchez-Ortí, JV, Correa-Ghisays, P, Balanzá-Martínez, V, López-Carrilero, R, Bobes-Bascarán, T, Catalán, A, Aymerich, C, Díaz-Mandado, O, Guinart, D, Vilella, E, García-Alvarez, L, Ochoa, S, Miret, S, Falip, C, Fernández-Martínez, R, García-Cabeza, I, Campos-Rodriguez, C, Crosas, JM, Cobo, J, Pardina-Torner, H, Perona-Garcelán, S, Yorca-Ruiz, A, de la Foz, VOG, Ayesa-Arriola, R. Validation and normative data for the BAC app in Spanish-speaking individuals with psychosis and healthy controls. EUROPEAN PSYCHIATRY. 2025; 68(1)DOI:10.1192/j.eurpsy.2025.10076. PMID:40785579. IF:6.700(Q1/1D).
01/08/2025
Targeting hallucinations in schizophrenia: Improving research translation into clinical practice
Corripio, I, Roldán, A. Targeting hallucinations in schizophrenia: Improving research translation into clinical practice. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 97DOI:10.1016/j.euroneuro.2025.05.005. PMID:40409235. IF:6.700(Q1/1D).
01/08/2025
Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk
He, JC, Alhamwe, BA, Sabroso, S, Carrato, A, Hidalgo, M, Molero, X, Iglesias, M, Perea, J, Farré, A, Tardón, A, Dominguez-Muñoz, E, Barberà, V, Muñoz-Bellvís, L, Löhr, M, Greenhalf, W, O'Rorke, M, Gress, T, Crnogorac-Jurcevic, T, Gayà, A, Langtry, A, Kleeff, J, Lawlor, R, Real, FX, Renz, H, Malats, N, PanGenEU Study Investigators. Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk. INTERNATIONAL JOURNAL OF CANCER. 2025; 157(3)DOI:10.1002/ijc.35397. PMID:40098454. IF:4.700(Q1/3D).